Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,041 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Protein tyrosine phosphatase receptor type C (PTPRC or CD45).
Al Barashdi MA, Ali A, McMullin MF, Mills K. Al Barashdi MA, et al. Among authors: mills k. J Clin Pathol. 2021 Sep;74(9):548-552. doi: 10.1136/jclinpath-2020-206927. Epub 2021 May 26. J Clin Pathol. 2021. PMID: 34039664 Free PMC article. Review.
Molecular pathogenesis of the myeloproliferative neoplasms.
Greenfield G, McMullin MF, Mills K. Greenfield G, et al. Among authors: mills k. J Hematol Oncol. 2021 Jun 30;14(1):103. doi: 10.1186/s13045-021-01116-z. J Hematol Oncol. 2021. PMID: 34193229 Free PMC article. Review.
TP53 Mutations Identified Using NGS Comprise the Overwhelming Majority of TP53 Disruptions in CLL: Results From a Multicentre Study.
Catherwood MA, Wren D, Chiecchio L, Cavalieri D, Donaldson D, Lawless S, ElHassadi E, Hayat A, Cahill MR, O'Shea D, Sargent J, Stewart P, Maurya M, Quinn J, Murphy P, de Castro DG, Mills K, Cross NCP, Forconi F, Iyengar S, Schuh A, Thornton P. Catherwood MA, et al. Among authors: mills k. Front Oncol. 2022 Jun 28;12:909615. doi: 10.3389/fonc.2022.909615. eCollection 2022. Front Oncol. 2022. PMID: 35837095 Free PMC article.
Epigenetics in Myeloproliferative Neoplasms.
McPherson S, McMullin MF, Mills K. McPherson S, et al. Among authors: mills k. J Cell Mol Med. 2017 Sep;21(9):1660-1667. doi: 10.1111/jcmm.13095. Epub 2017 Jul 4. J Cell Mol Med. 2017. PMID: 28677265 Free PMC article. Review.
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia.
Diop F, Moia R, Favini C, Spaccarotella E, De Paoli L, Bruscaggin A, Spina V, Terzi-di-Bergamo L, Arruga F, Tarantelli C, Deambrogi C, Rasi S, Adhinaveni R, Patriarca A, Favini S, Sagiraju S, Jabangwe C, Kodipad AA, Peroni D, Mauro FR, Giudice ID, Forconi F, Cortelezzi A, Zaja F, Bomben R, Rossi FM, Visco C, Chiarenza A, Rigolin GM, Marasca R, Coscia M, Perbellini O, Tedeschi A, Laurenti L, Motta M, Donaldson D, Weir P, Mills K, Thornton P, Lawless S, Bertoni F, Poeta GD, Cuneo A, Follenzi A, Gattei V, Boldorini RL, Catherwood M, Deaglio S, Foà R, Gaidano G, Rossi D. Diop F, et al. Among authors: mills k. Haematologica. 2020 Jan 31;105(2):448-456. doi: 10.3324/haematol.2019.219550. Print 2020. Haematologica. 2020. PMID: 31371416 Free PMC article.
Patients with triple-negative, JAK2V617F- and CALR-mutated essential thrombocythemia share a unique gene expression signature.
Alimam S, Villiers W, Dillon R, Simpson M, Runglall M, Smith A, Chatzikyriakou P, Lavender P, Kanda A, Mills K, Bellosillo Paricio B, Kaufman-Cook J, Ord S, Kordasti S, Radia D, Woodley C, Francis Y, Mufti G, McLornan DP, Harrison CN. Alimam S, et al. Among authors: mills k. Blood Adv. 2021 Feb 23;5(4):1059-1068. doi: 10.1182/bloodadvances.2020003172. Blood Adv. 2021. PMID: 33599741 Free PMC article.
Relevance of TP53 for CLL diagnostics.
Catherwood MA, Gonzalez D, Donaldson D, Clifford R, Mills K, Thornton P. Catherwood MA, et al. Among authors: mills k. J Clin Pathol. 2019 May;72(5):343-346. doi: 10.1136/jclinpath-2018-205622. Epub 2019 Feb 2. J Clin Pathol. 2019. PMID: 30712002 Review.
2,041 results